Description

FibroScan: The Gold Standard for Non-Invasive Liver Assessment FibroScan (Transient Elastography) is an advanced, non-invasive diagnostic tool used to assess liver stiffness and fat content, playing a crucial role in evaluating chronic liver diseases such as MAFLD, viral hepatitis, alcohol-related liver disease, and cirrhosis. By measuring Liver Stiffness Measurement (LSM) in kilopascals (kPa) and Controlled Attenuation Parameter (CAP) in dB/m, FibroScan helps quantify fibrosis (scarring) and steatosis (fat accumulation) with high accuracy, reducing the need for liver biopsies. Key Features & Clinical Utility: 🔹 Quick & Painless: Takes 5-10 minutes, performed at the bedside, and requires no sedation. 🔹 Early Detection: Identifies fibrosis progression in at-risk populations before symptoms appear. 🔹 Risk Stratification: Differentiates between simple fatty liver and advanced fibrosis/cirrhosis, guiding treatment decisions. 🔹 Monitoring Tool: Tracks liver disease progression or regression post-intervention (weight loss, antiviral therapy, or metabolic control). Interpreting Results: ✔️ CAP Score (dB/m): <248 dB/m: Minimal or no fat 248–280 dB/m: Mild steatosis >280 dB/m: Significant fat accumulation (severe steatosis) ✔️ LSM (kPa): <7 kPa: No/mild fibrosis 7-12 kPa: Moderate fibrosis (F2-F3) >12 kPa: Advanced fibrosis/cirrhosis (F4) Why It Matters? With the rising burden of MAFLD & liver-related complications, FibroScan is transforming hepatology practice—allowing early diagnosis, risk prediction, and personalized liver care without invasive procedures. #FibroScan #LiverHealth #FattyLiver #Cirrhosis #Hepatology #NonInvasiveTesting #PrecisionMedicine #drchetankalal #besthepatologistmumbai # besthepatologistindia